Accelerated Weathering Test Chamber
The research report includes specific segments by region (country), by manufacturers, by Volume a ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Phenotypic Drug Discovery Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Platform 1.2.3 Service 1.3 Market by Application 1.3.1 Global Phenotypic Drug Discovery Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Cancer 1.3.3 Viral Infection 1.3.4 Genetic Disease 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Phenotypic Drug Discovery Market Perspective (2017-2028) 2.2 Phenotypic Drug Discovery Growth Trends by Region 2.2.1 Phenotypic Drug Discovery Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Phenotypic Drug Discovery Historic Market Size by Region (2017-2022) 2.2.3 Phenotypic Drug Discovery Forecasted Market Size by Region (2023-2028) 2.3 Phenotypic Drug Discovery Market Dynamics 2.3.1 Phenotypic Drug Discovery Industry Trends 2.3.2 Phenotypic Drug Discovery Market Drivers 2.3.3 Phenotypic Drug Discovery Market Challenges 2.3.4 Phenotypic Drug Discovery Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Phenotypic Drug Discovery Players by Revenue 3.1.1 Global Top Phenotypic Drug Discovery Players by Revenue (2017-2022) 3.1.2 Global Phenotypic Drug Discovery Revenue Market Share by Players (2017-2022) 3.2 Global Phenotypic Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Phenotypic Drug Discovery Revenue 3.4 Global Phenotypic Drug Discovery Market Concentration Ratio 3.4.1 Global Phenotypic Drug Discovery Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Phenotypic Drug Discovery Revenue in 2021 3.5 Phenotypic Drug Discovery Key Players Head office and Area Served 3.6 Key Players Phenotypic Drug Discovery Product Solution and Service 3.7 Date of Enter into Phenotypic Drug Discovery Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Phenotypic Drug Discovery Breakdown Data by Type 4.1 Global Phenotypic Drug Discovery Historic Market Size by Type (2017-2022) 4.2 Global Phenotypic Drug Discovery Forecasted Market Size by Type (2023-2028) 5 Phenotypic Drug Discovery Breakdown Data by Application 5.1 Global Phenotypic Drug Discovery Historic Market Size by Application (2017-2022) 5.2 Global Phenotypic Drug Discovery Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Phenotypic Drug Discovery Market Size (2017-2028) 6.2 North America Phenotypic Drug Discovery Market Size by Country (2017-2022) 6.3 North America Phenotypic Drug Discovery Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Phenotypic Drug Discovery Market Size (2017-2028) 7.2 Europe Phenotypic Drug Discovery Market Size by Country (2017-2022) 7.3 Europe Phenotypic Drug Discovery Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Phenotypic Drug Discovery Market Size (2017-2028) 8.2 Asia-Pacific Phenotypic Drug Discovery Market Size by Country (2017-2022) 8.3 Asia-Pacific Phenotypic Drug Discovery Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Phenotypic Drug Discovery Market Size (2017-2028) 9.2 Latin America Phenotypic Drug Discovery Market Size by Country (2017-2022) 9.3 Latin America Phenotypic Drug Discovery Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Phenotypic Drug Discovery Market Size (2017-2028) 10.2 Middle East & Africa Phenotypic Drug Discovery Market Size by Country (2017-2022) 10.3 Middle East & Africa Phenotypic Drug Discovery Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Eurofins Discovery 11.1.1 Eurofins Discovery Company Detail 11.1.2 Eurofins Discovery Business Overview 11.1.3 Eurofins Discovery Phenotypic Drug Discovery Introduction 11.1.4 Eurofins Discovery Revenue in Phenotypic Drug Discovery Business (2017-2022) 11.1.5 Eurofins Discovery Recent Development 11.2 Sygnature Discovery 11.2.1 Sygnature Discovery Company Detail 11.2.2 Sygnature Discovery Business Overview 11.2.3 Sygnature Discovery Phenotypic Drug Discovery Introduction 11.2.4 Sygnature Discovery Revenue in Phenotypic Drug Discovery Business (2017-2022) 11.2.5 Sygnature Discovery Recent Development 11.3 PsychoGenics 11.3.1 PsychoGenics Company Detail 11.3.2 PsychoGenics Business Overview 11.3.3 PsychoGenics Phenotypic Drug Discovery Introduction 11.3.4 PsychoGenics Revenue in Phenotypic Drug Discovery Business (2017-2022) 11.3.5 PsychoGenics Recent Development 11.4 siTOOLs Biotech 11.4.1 siTOOLs Biotech Company Detail 11.4.2 siTOOLs Biotech Business Overview 11.4.3 siTOOLs Biotech Phenotypic Drug Discovery Introduction 11.4.4 siTOOLs Biotech Revenue in Phenotypic Drug Discovery Business (2017-2022) 11.4.5 siTOOLs Biotech Recent Development 11.5 PhoreMost 11.5.1 PhoreMost Company Detail 11.5.2 PhoreMost Business Overview 11.5.3 PhoreMost Phenotypic Drug Discovery Introduction 11.5.4 PhoreMost Revenue in Phenotypic Drug Discovery Business (2017-2022) 11.5.5 PhoreMost Recent Development 11.6 Charles River 11.6.1 Charles River Company Detail 11.6.2 Charles River Business Overview 11.6.3 Charles River Phenotypic Drug Discovery Introduction 11.6.4 Charles River Revenue in Phenotypic Drug Discovery Business (2017-2022) 11.6.5 Charles River Recent Development 11.7 MaxWell 11.7.1 MaxWell Company Detail 11.7.2 MaxWell Business Overview 11.7.3 MaxWell Phenotypic Drug Discovery Introduction 11.7.4 MaxWell Revenue in Phenotypic Drug Discovery Business (2017-2022) 11.7.5 MaxWell Recent Development 11.8 Arctoris 11.8.1 Arctoris Company Detail 11.8.2 Arctoris Business Overview 11.8.3 Arctoris Phenotypic Drug Discovery Introduction 11.8.4 Arctoris Revenue in Phenotypic Drug Discovery Business (2017-2022) 11.8.5 Arctoris Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Phenotypic Drug Discovery Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Platform Table 3. Key Players of Service Table 4. Global Phenotypic Drug Discovery Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global Phenotypic Drug Discovery Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Phenotypic Drug Discovery Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Phenotypic Drug Discovery Market Share by Region (2017-2022) Table 8. Global Phenotypic Drug Discovery Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Phenotypic Drug Discovery Market Share by Region (2023-2028) Table 10. Phenotypic Drug Discovery Market Trends Table 11. Phenotypic Drug Discovery Market Drivers Table 12. Phenotypic Drug Discovery Market Challenges Table 13. Phenotypic Drug Discovery Market Restraints Table 14. Global Phenotypic Drug Discovery Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Phenotypic Drug Discovery Market Share by Players (2017-2022) Table 16. Global Top Phenotypic Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phenotypic Drug Discovery as of 2021) Table 17. Ranking of Global Top Phenotypic Drug Discovery Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Phenotypic Drug Discovery Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Phenotypic Drug Discovery Product Solution and Service Table 21. Date of Enter into Phenotypic Drug Discovery Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Phenotypic Drug Discovery Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Phenotypic Drug Discovery Revenue Market Share by Type (2017-2022) Table 25. Global Phenotypic Drug Discovery Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Phenotypic Drug Discovery Revenue Market Share by Type (2023-2028) Table 27. Global Phenotypic Drug Discovery Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Phenotypic Drug Discovery Revenue Market Share by Application (2017-2022) Table 29. Global Phenotypic Drug Discovery Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Phenotypic Drug Discovery Revenue Market Share by Application (2023-2028) Table 31. North America Phenotypic Drug Discovery Market Size by Country (2017-2022) & (US$ Million) Table 32. North America Phenotypic Drug Discovery Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe Phenotypic Drug Discovery Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe Phenotypic Drug Discovery Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific Phenotypic Drug Discovery Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific Phenotypic Drug Discovery Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America Phenotypic Drug Discovery Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America Phenotypic Drug Discovery Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa Phenotypic Drug Discovery Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa Phenotypic Drug Discovery Market Size by Country (2023-2028) & (US$ Million) Table 41. Eurofins Discovery Company Detail Table 42. Eurofins Discovery Business Overview Table 43. Eurofins Discovery Phenotypic Drug Discovery Product Table 44. Eurofins Discovery Revenue in Phenotypic Drug Discovery Business (2017-2022) & (US$ Million) Table 45. Eurofins Discovery Recent Development Table 46. Sygnature Discovery Company Detail Table 47. Sygnature Discovery Business Overview Table 48. Sygnature Discovery Phenotypic Drug Discovery Product Table 49. Sygnature Discovery Revenue in Phenotypic Drug Discovery Business (2017-2022) & (US$ Million) Table 50. Sygnature Discovery Recent Development Table 51. PsychoGenics Company Detail Table 52. PsychoGenics Business Overview Table 53. PsychoGenics Phenotypic Drug Discovery Product Table 54. PsychoGenics Revenue in Phenotypic Drug Discovery Business (2017-2022) & (US$ Million) Table 55. PsychoGenics Recent Development Table 56. siTOOLs Biotech Company Detail Table 57. siTOOLs Biotech Business Overview Table 58. siTOOLs Biotech Phenotypic Drug Discovery Product Table 59. siTOOLs Biotech Revenue in Phenotypic Drug Discovery Business (2017-2022) & (US$ Million) Table 60. siTOOLs Biotech Recent Development Table 61. PhoreMost Company Detail Table 62. PhoreMost Business Overview Table 63. PhoreMost Phenotypic Drug Discovery Product Table 64. PhoreMost Revenue in Phenotypic Drug Discovery Business (2017-2022) & (US$ Million) Table 65. PhoreMost Recent Development Table 66. Charles River Company Detail Table 67. Charles River Business Overview Table 68. Charles River Phenotypic Drug Discovery Product Table 69. Charles River Revenue in Phenotypic Drug Discovery Business (2017-2022) & (US$ Million) Table 70. Charles River Recent Development Table 71. MaxWell Company Detail Table 72. MaxWell Business Overview Table 73. MaxWell Phenotypic Drug Discovery Product Table 74. MaxWell Revenue in Phenotypic Drug Discovery Business (2017-2022) & (US$ Million) Table 75. MaxWell Recent Development Table 76. Arctoris Company Detail Table 77. Arctoris Business Overview Table 78. Arctoris Phenotypic Drug Discovery Product Table 79. Arctoris Revenue in Phenotypic Drug Discovery Business (2017-2022) & (US$ Million) Table 80. Arctoris Recent Development Table 81. Research Programs/Design for This Report Table 82. Key Data Information from Secondary Sources Table 83. Key Data Information from Primary Sources List of Figures Figure 1. Global Phenotypic Drug Discovery Market Share by Type: 2021 VS 2028 Figure 2. Platform Features Figure 3. Service Features Figure 4. Global Phenotypic Drug Discovery Market Share by Application in 2021 & 2028 Figure 5. Cancer Case Studies Figure 6. Viral Infection Case Studies Figure 7. Genetic Disease Case Studies Figure 8. Others Case Studies Figure 9. Phenotypic Drug Discovery Report Years Considered Figure 10. Global Phenotypic Drug Discovery Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Phenotypic Drug Discovery Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Phenotypic Drug Discovery Market Share by Region: 2021 VS 2028 Figure 13. Global Phenotypic Drug Discovery Market Share by Players in 2021 Figure 14. Global Top Phenotypic Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phenotypic Drug Discovery as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Phenotypic Drug Discovery Revenue in 2021 Figure 16. North America Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million) Figure 17. North America Phenotypic Drug Discovery Market Share by Country (2017-2028) Figure 18. United States Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Phenotypic Drug Discovery Market Share by Country (2017-2028) Figure 22. Germany Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. France Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. U.K. Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Italy Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Russia Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Nordic Countries Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Phenotypic Drug Discovery Market Share by Region (2017-2028) Figure 30. China Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Japan Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. South Korea Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Southeast Asia Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. India Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Australia Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Phenotypic Drug Discovery Market Share by Country (2017-2028) Figure 38. Mexico Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Brazil Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Phenotypic Drug Discovery Market Share by Country (2017-2028) Figure 42. Turkey Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Saudi Arabia Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Eurofins Discovery Revenue Growth Rate in Phenotypic Drug Discovery Business (2017-2022) Figure 45. Sygnature Discovery Revenue Growth Rate in Phenotypic Drug Discovery Business (2017-2022) Figure 46. PsychoGenics Revenue Growth Rate in Phenotypic Drug Discovery Business (2017-2022) Figure 47. siTOOLs Biotech Revenue Growth Rate in Phenotypic Drug Discovery Business (2017-2022) Figure 48. PhoreMost Revenue Growth Rate in Phenotypic Drug Discovery Business (2017-2022) Figure 49. Charles River Revenue Growth Rate in Phenotypic Drug Discovery Business (2017-2022) Figure 50. MaxWell Revenue Growth Rate in Phenotypic Drug Discovery Business (2017-2022) Figure 51. Arctoris Revenue Growth Rate in Phenotypic Drug Discovery Business (2017-2022) Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation Figure 54. Key Executives Interviewed
Eurofins Discovery Sygnature Discovery PsychoGenics siTOOLs Biotech PhoreMost Charles River MaxWell Arctoris
The research report includes specific segments by region (country), by manufacturers, by Volume a ... Read More
Rx Products for Bacterial Vaginosis market is segmented by players, region (country), by Type and ... Read More
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
The research report includes specific segments by region (country), by company, by Pixel Size and ... Read More